Labcorp(LH) - 2023 Q1 - Earnings Call Presentation

(k) (I) 16 April 25, 2023 Cautionary Statement Regarding Forward-Looking This presentation contains forward-looking statements, including, but not limited to, statements with respect to (i) the estimated 2023 guidance and the longer-term outlook and the related assumptions of each, (ii) the proposed spin-off of the Clinical Development business ("CD"), including statements regarding the expectation that the spin-off transaction ("Transaction") will be consummated, the anticipated timing of the Transaction, ...